• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Gen-Probe: New Tests Key to Increasing Revenue

    Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.

  2. Paying Up and Paying Out

    News this week showed market players paying up for media assets, paying out for tax relief, and more.

  3. The Moat in Your Medicine Cabinet

    Aptar COO Steve Hagge on how the firm's close client relationships and FDA-approved dispensers give the firm an advantage in consumer packaging.

  4. Lorillard Bonds Attractive Ahead of FDA Ruling

    Worries about the FDA's ruling on the relative safety of menthol cigarettes have left Lorillard's bonds looking attractively priced according to Morningstar's Dave Sekera.

  1. Gilead Sciences, Inc. GILD Q1 2010 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by. We would like to welcome you to the Gilead Sciences First Quarter 2010 Earnings Conference Call. My name is Stacy and I will be your conference operator for today.

  2. Gilead Sciences, Inc. GILD Q2 2010 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by and welcome to the Gilead Sciences Second Quarter 2010 Earnings Conference Call. My name is Stacey and I will be your conference operator for today.

  3. Gilead Sciences, Inc. GILD Q3 2010 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by and welcome to the Gilead Sciences' Third Quarter 2010 Earnings Conference Call. My name is Stacey and I will be your conference operator for today.

  4. Gilead Sciences, Inc. GILD Q4 2010 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by and welcome to Gilead Sciences' Fourth Quarter 2010 Earnings Conference Call. My name is Stacey and I will be your conference operator today.

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.